Radiation Medicine Program

📢New: RMP 2024–2025 Annual Report Excited to share RMP’s 2024–2025 Annual Report, showcasing a year of groundbreaking research, innovative education, and exceptional patient care. Proud of everything our teams have accomplished! 🔗: uhn.ca/PrincessMargar…

@UHN_Research @SickKidsCancer @SinaiHealth 🔬This workshop brings together leading researchers to explore the latest breakthroughs in TP53 - from its fundamental role in human biology and genomics to its impact on health, disease, and cancer therapeutics. Full agenda: p53.mshri.on.ca/?page=prog

🚨 Registration for the 20th International p53 workshop closes March 31 🚨 Don’t miss your spot at this important meeting co‑hosted by three of Canada’s leading research institutions: @UHN_Research @SickKidsCancer @SinaiHealth 👉Register now: p53.mshri.on.ca/?page=838

Applications are now open for the 2026 International Undergraduate Radiation Therapist Training Academy (IURTTA), hosted by #RMPatPM's Accelerated Education Program!

New multidisciplinary #RMPatPM study from Dr. Monica Serban & team in @RO_GreenJournal examines how anatomical changes and setup uncertainties affect lattice integrity and delivered dose in spatially and temporally fractionated Lattice Radiotherapy.🔗: doi.org/10.1016/j.rado…

This week, we announced the second class of inductees into the Princess Margaret Hall of Fame, recognizing six distinguished leaders for their foundational work and excellence in cancer care, research, and education. Learn more about their work: #pm-inductees" target="_blank" rel="nofollow noopener">uhn.ca/corporate/news…

📢 @CIHR_IRSC and partners have announced a $41M+ national investment in cancer prevention and early diagnosis research. @PMResearch_UHN scientists, Drs. Steven Chan and Faiyaz Notta are among the 19 teams supported through this initiative. 🔗Learn more: uhnresearch.ca/news/major-boo…

New research from #RMPatPM medical physicist Dr. Tony Tadic and team evaluate a prostate MR-to-MR deformable image registration (DIR) method to support MR-guided adaptive radiotherapy. 🔗: doi.org/10.1002/acm2.7…

Recent study from #RMPatPM Dr. Aruz Mesci, former RMP fellow Dr. Saheli Saha, and team, published in @CurrentOncology, examines outcomes of short-course radiotherapy for cholangiocarcinoma. 🔗: doi.org/10.3390/curron…

💡New article from Radiation Therapist Vickie Kong and team looks at time toxicity in CBCT-guided radiation therapy using a retrospective analysis🔗: doi.org/10.1016/j.tips…

We are lucky @UofTDRO to work with talented residents & fellows from across Canada and around the world. Thank you for outstanding care of our cancer patients and for your impactful contributions to research and education. @RadMedPM @Sunnybrook @UHN @ldawsonmd @SahgalArjun

@MichaelYanMD @ldawsonmd @CIHR_IRSC 🎉Additional congratulations to Dr. Yan for receiving the Institute of Cancer Research's Early Career Research Award in Cancer for this project!

🎉Big congratulations to #RMPatPM researchers Drs. @MichaelYanMD and @ldawsonmd on receiving a $210,000 @CIHR_IRSC grant for their project, “A randomised controlled trial of Standard of Care versus RadioAblaTion in Early Stage HCC (The SOCRATES HCC Study).”

🎉Congratulations to the Head of #RMPatPM @DKirschMDPhD on securing a $1.37 million @CIHR_IRSC grant for his project "Dissecting T cell immune and therapeutic responses against soft tissue sarcomas."

During a short visit to @KHCC, glad to see @IssaMohamadRad treat the first enrolled patients at #ULTRAS phase III RCT with 38Gy single Fx for liver met with MR adaptive SBRT @Xristodouleas @aguilera_md @SweetPingNg @RadMedPM @Hendo_tan

New article from #RMPatPM's Drs. Philip Wong, Hiba Othman & team details prospective PROMPT trial, exploring feasibility of integrating biometric monitoring for patients with metastatic cancer receiving palliative radiotherapy for symptom management.🔗: doi.org/10.21037/apm-2…

🚨Reminder: The 20th International p53 Workshop is still accepting trainee abstracts until Jan. 31st 5PM ET! Don’t miss your chance to present at this global event! 📅Deadline for early bird pricing is Feb. 1st. 📍Toronto | Apr 27–May 1, 2026 🔗Submit now: p53.mshri.on.ca

Read this #RedJournal article about a prospective phase 2 trial of renal SBRT demonstrating modest decline in renal function following treatment and excellent cancer control rates @r_glicksman @JA_Helou @UroOncMD @RHamiltonUrol @aleberlin2 @onconeph @radmedPM @UofTDRO @UHN_Research tinyurl.com/rjglicksman

📢Exciting news! The deadline for trainee abstracts has been extended to January 31st (5PM ET). Don’t miss your chance to present at this global event! 📅Deadline for early bird pricing is February 1st. 🔗 Submit now: p53.mshri.on.ca

🚨 Reminder for trainees: The 20th International p53 Workshop is accepting abstracts! 📅 Deadline: Dec 31, 2025 (5 PM EDT) 📍 Toronto | Apr 27–May 1, 2026 🔗 Submit now: p53.mshri.on.ca Don’t miss your chance to present at this global event! #TP53 #CancerResearch